A review of gene therapy in canine and feline models of lysosomal storage disorders [PDF]
Bradbury, Allison M +5 more
core +2 more sources
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunction.
Glycosphingolipids (GSL) are important bioactive membrane components. GSLs containing sialic acids, known as gangliosides, are highly abundant in the brain and diseases of ganglioside metabolism cause severe early-onset neurodegeneration. The ganglioside
Alex S Nicholson +11 more
doaj +1 more source
Abnormal epiphyseal development in a feline model of Sandhoff disease. [PDF]
McNulty MA +9 more
europepmc +1 more source
Linear ion-trap MSn with high-resolution MS reveals structural diversity of 1-O-acylceramide family in mouse epidermis [PDF]
Hsu, Fong-Fu +3 more
core +2 more sources
A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease). [PDF]
Davies EH, Johnston J, Toro C, Tifft CJ.
europepmc +1 more source
Bioprinting neural tissue to decode Sandhoff disease: promise and barriers. [PDF]
Ullah SH +4 more
europepmc +1 more source
Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease [PDF]
et al,, Jiang, Xuntian, Ory, Daniel S
core +1 more source
Subacute Juvenile Sandhoff Disease: A Progressive Neurodegenerative Disorder. [PDF]
Kadam BD +3 more
europepmc +1 more source
The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations [PDF]
Helena Poupětová +5 more
core +1 more source
AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease. [PDF]
Bradbury AM +15 more
europepmc +1 more source

